Logo

American Heart Association

  35
  0


Final ID:

Wrap: State of Cardiac Amyloid 2026

  • Kittleson, Michelle  ( Smidt Heart Institute, Cedars-Sinai , Beverly Hills , California , United States )
  • Mauer, Matthew  ( KCMO , Kansas City , Missouri , United States )
  • Author Disclosures:
    Michelle Kittleson: DO NOT have relevant financial relationships | Matthew Mauer: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure

Monday, 11/10/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Primary results from the phase 2 randomized, placebo controlled, blinded trial of the monoclonal antibody coramitug in transthyretin amyloid cardiomyopathy (ATTR-CM)

Fontana Marianna, Kar Soumitra, Revanna Manjunatha, Sarswat Nitasha, Tsujita Kenichi, Maurer Mathew, Garcia-pavia Pablo, Grogan Martha, Shah Sanjiv, Engelmann Mads, Hovingh G. Kees, Kristen Arnt, Lim-watson Michelle, Malling Brian

Commentary: Mab Therapy for Cardiac Amyloid

Alexander Kevin, Witteles Ronald

More abstracts from these authors:
Panelist - HF

Drazner Mark, Kittleson Michelle

The Final Battle: Advanced Heart Failure and AF - HF Top 5 Take Aways

Ambardekar Amrut, Kittleson Michelle

You have to be authorized to contact abstract author. Please, Login
Not Available